T1	PROC 44 75	Estudio de eficacia y seguridad
T2	DISO 107 125	enfermdad de Crohn
T3	PROC 168 254	Estudio de inducción multicéntrico, aleatorizado, doble ciego y controlado con placebo
T4	CHEM 1810 1822	risankizumab
#1	AnnotatorNotes T4	C4505511; risankizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T5	PROC 260 294	evaluar la eficacia y la seguridad
#2	AnnotatorNotes T5	C0511730; Identify product efficacy and safety issues; Health Care Activity
T6	DISO 326 345	enfermedad de Crohn
#3	AnnotatorNotes T6	C0010346; Crohn Disease; Disease or Syndrome
T7	DISO 392 411	Enfermedad de Cronh
T8	DISO 437 456	Enfermedad de Crohn
#4	AnnotatorNotes T8	C0010346; Crohn Disease; Disease or Syndrome
T9	PROC 714 725	Diagnóstico
#5	AnnotatorNotes T9	C0011900; Diagnosis; Diagnostic Procedure
T10	DISO 729 748	Enfermedad de Crohn
#6	AnnotatorNotes T10	C0010346; Crohn Disease; Disease or Syndrome
T11	DISO 841 860	enfermedad de Crohn
#7	AnnotatorNotes T11	C0010346; Crohn Disease; Disease or Syndrome
T12	PROC 889 900	Diagnóstico
#8	AnnotatorNotes T12	C0011900; Diagnosis; Diagnostic Procedure
T13	DISO 915 934	enfermedad de Crohn
#9	AnnotatorNotes T13	C0010346; Crohn Disease; Disease or Syndrome
T14	ANAT 978 983	heces
#10	AnnotatorNotes T14	C0015733; Feces; Body Substance
T15	DISO 1004 1019	dolor abdominal
#11	AnnotatorNotes T15	C0000737; Abdominal Pain; Sign or Symptom
T17	DISO 1068 1087	enfermedad de Crohn
#13	AnnotatorNotes T17	C0010346; Crohn Disease; Disease or Syndrome
T18	PROC 1148 1180	terapia convencional o biológica
T19	DISO 1186 1205	enfermedad de Crohn
#14	AnnotatorNotes T19	C0010346; Crohn Disease; Disease or Syndrome
T20	PROC 1261 1275	anticoncepción
#15	AnnotatorNotes T20	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T21	PROC 1318 1329	diagnóstico
#16	AnnotatorNotes T21	C0011900; Diagnosis; Diagnostic Procedure
T22	DISO 1340 1356	colitis ulcerosa
#17	AnnotatorNotes T22	C0009324; Ulcerative Colitis; Disease or Syndrome
T23	DISO 1359 1380	colitis indeterminada
#18	AnnotatorNotes T23	C0341332; Indeterminate colitis; Disease or Syndrome
T24	PROC 1415 1435	terapia concomitante
#19	AnnotatorNotes T24	C1707479; Concomitant Therapy; Therapeutic or Preventive Procedure
T25	DISO 1444 1463	enfermedad de Crohn
#20	AnnotatorNotes T25	C0010346; Crohn Disease; Disease or Syndrome
T26	CHEM 1481 1499	agentes biológicos
#21	AnnotatorNotes T26	C0005515; Biological Factors; Biologically Active Substance
T27	DISO 1518 1537	enfermedad de Crohn
#22	AnnotatorNotes T27	C0010346; Crohn Disease; Disease or Syndrome
T28	CHEM 1606 1622	agente biológico
#23	AnnotatorNotes T28	C0005515; Biological Factors; Biologically Active Substance
T29	CHEM 1630 1653	agente de investigación
#24	AnnotatorNotes T29	C0013230; Investigational New Drugs; Pharmacologic Substance
T30	CHEM 1725 1740	inhibidores p40
T31	CHEM 1755 1766	ustekinumab
#25	AnnotatorNotes T31	C1608841; ustekinumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T32	CHEM 1768 1775	Stelara
#26	AnnotatorNotes T32	C2702169; Stelara; Immunologic Factor · Pharmacologic Substance
T33	CHEM 1780 1795	inhibidores p19
T34	DISO 1826 1840	Complicaciones
#27	AnnotatorNotes T34	C0009566; Complication; Pathologic Function
T35	DISO 1847 1866	enfermedad de Crohn
#28	AnnotatorNotes T35	C0010346; Crohn Disease; Disease or Syndrome
T36	DISO 1868 1877	estenosis
#29	AnnotatorNotes T36	C1261287; Stenosis; Pathologic Function
T37	DISO 1879 1894	intestino corto
T38	ANAT 1908 1935	bolsa de ostomía o ileoanal
T39	PROC 1917 1924	ostomía
#30	AnnotatorNotes T39	C0029473; Ostomy; Therapeutic or Preventive Procedure
T40	CHEM 79 91	Risankizumab
#31	AnnotatorNotes T40	C4505511; risankizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T41	CHEM 298 310	risankizumab
#32	AnnotatorNotes T41	C4505511; risankizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T42	ANAT 1010 1019	abdominal
#33	AnnotatorNotes T42	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T43	DISO 1099 1111	Intolerancia
#34	AnnotatorNotes T43	C0277585; Intolerance to drug; Pathologic Function
T44	ANAT 1879 1888	intestino
#35	AnnotatorNotes T44	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T45	Date 12 16	2016
T46	LIVB 95 102	sujetos
#36	AnnotatorNotes T46	C0681850; Study Subject; Group
T47	LIVB 314 321	sujetos
#37	AnnotatorNotes T47	C0681850; Study Subject; Group
T48	LIVB 493 498	mujer
#38	AnnotatorNotes T48	C0043210; Woman; Population Group
T49	Age 499 520	>= 18 años <= 80 años
T51	LIVB 587 594	sujetos
#39	AnnotatorNotes T51	C0681850; Study Subject; Group
T52	Age 595 611	de 16 a <18 años
T53	Duration 749 765	al menos 3 meses
T55	LIVB 1214 1219	mujer
#40	AnnotatorNotes T55	C0043210; Woman; Population Group
T56	LIVB 1304 1310	Sujeto
#41	AnnotatorNotes T56	C0681850; Study Subject; Group
T57	Date 1330 1336	actual
T58	LIVB 1383 1390	Sujetos
#42	AnnotatorNotes T58	C0681850; Study Subject; Group
T59	Duration 1549 1562	las 8 semanas
T60	Duration 1657 1677	un mínimo de 35 días
T61	LIVB 485 490	Varón
#43	AnnotatorNotes T61	C0025266; Male population group; Population Group
T50	Dose 1395 1411	dosis inestables
T62	PROC 686 692	Tanner
#44	AnnotatorNotes T62	C0431029; Tanner bone age assessment; Diagnostic Procedure
T54	PROC 541 547	visita
#45	AnnotatorNotes T54	C1512346; Patient Visit; Health Care Activity
T63	PROC 699 705	visita
#46	AnnotatorNotes T63	C1512346; Patient Visit; Health Care Activity
T64	PROC 778 784	visita
#47	AnnotatorNotes T64	C1512346; Patient Visit; Health Care Activity
T65	PROC 874 880	visita
#48	AnnotatorNotes T65	C1512346; Patient Visit; Health Care Activity
T66	PROC 1579 1585	visita
#49	AnnotatorNotes T66	C1512346; Patient Visit; Health Care Activity
T67	PROC 1690 1696	visita
#50	AnnotatorNotes T67	C1512346; Patient Visit; Health Care Activity
T68	Quantifier_or_Qualifier 1697 1702	basal
#51	AnnotatorNotes T68	C1442488; Baseline; Quantitative Concept
T69	Quantifier_or_Qualifier 1586 1591	basal
#52	AnnotatorNotes T69	C1442488; Baseline; Quantitative Concept
T70	Quantifier_or_Qualifier 881 886	basal
#53	AnnotatorNotes T70	C1442488; Baseline; Quantitative Concept
T71	Quantifier_or_Qualifier 785 790	basal
#54	AnnotatorNotes T71	C1442488; Baseline; Quantitative Concept
T72	Quantifier_or_Qualifier 706 711	basal
#55	AnnotatorNotes T72	C1442488; Baseline; Quantitative Concept
T73	Quantifier_or_Qualifier 548 553	basal
#56	AnnotatorNotes T73	C1442488; Baseline; Quantitative Concept
A1	Status T30 History_of
A2	Status T31 History_of
A3	Status T32 History_of
A4	Status T33 History_of
A5	Status T4 History_of
A6	Status T26 History_of
A7	Status T28 History_of
A8	Status T29 History_of
#57	AnnotatorNotes T2	C0010346; Crohn Disease; Disease or Syndrome
#58	AnnotatorNotes T7	C0010346; Crohn Disease; Disease or Syndrome
#59	AnnotatorNotes T1	C0511730; Identify product efficacy and safety issues; Health Care Activity
#60	AnnotatorNotes T3	C5202807; Induction Therapy; Therapeutic or Preventive Procedure + C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#61	AnnotatorNotes T57	C0521116; Current (present time); Temporal Concept 
R1	Experiences Arg1:T46 Arg2:T40	
R2	Experiences Arg1:T46 Arg2:T2	
T74	Quantifier_or_Qualifier 129 146	moderada a severa
#62	AnnotatorNotes T74	C1299393; Moderate to severe; Qualitative Concept
R3	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T74	
T75	Quantifier_or_Qualifier 353 369	moderada o grave
#63	AnnotatorNotes T75	C1299393; Moderate to severe; Qualitative Concept
R4	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T75	
R5	Experiences Arg1:T47 Arg2:T41	
R6	Experiences Arg1:T47 Arg2:T6	
T76	Quantifier_or_Qualifier 346 352	activa
#64	AnnotatorNotes T76	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R7	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T76	
R8	Has_Age Arg1:T61 Arg2:T49	
R9	Has_Age Arg1:T48 Arg2:T49	
R10	Overlap Arg1:T54 Arg2:T49	
R11	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T73	
R12	Has_Age Arg1:T51 Arg2:T52	
T77	Result_or_Value 639 648	estadío 5
R13	Has_Result_or_Value Arg1:T62 Arg2:T77	
R14	Overlap Arg1:T62 Arg2:T63	
R15	Has_Quantifier_or_Qualifier Arg1:T63 Arg2:T72	
R16	Experiences Arg1:T51 Arg2:T62	
R17	Overlap Arg1:T63 Arg2:T52	
R18	Has_Quantifier_or_Qualifier Arg1:T64 Arg2:T71	
R19	Has_Duration_or_Interval Arg1:T10 Arg2:T53	
R20	Before Arg1:T10 Arg2:T64	
R21	Before Arg1:T9 Arg2:T64	
T78	PROC 815 860	Índice de actividad de la enfermedad de Crohn
#65	AnnotatorNotes T78	C5566328; Assessment using Crohn's Disease Activity Index; Health Care Activity
T79	PROC 862 866	CDAI
#66	AnnotatorNotes T79	C5566328; Assessment using Crohn's Disease Activity Index; Health Care Activity
T80	Result_or_Value 804 811	220-450
R22	Has_Result_or_Value Arg1:T78 Arg2:T80	
R23	Has_Result_or_Value Arg1:T79 Arg2:T80	
R24	Overlap Arg1:T78 Arg2:T65	
R25	Overlap Arg1:T79 Arg2:T65	
R26	Has_Quantifier_or_Qualifier Arg1:T65 Arg2:T70	
T81	Quantifier_or_Qualifier 938 954	moderada a grave
#67	AnnotatorNotes T81	C1299393; Moderate to severe; Qualitative Concept
R27	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T81	
T82	Observation 964 983	frecuencia de heces
#68	AnnotatorNotes T82	C0426642; Frequency of bowel action; Finding
R28	Location_of Arg1:T42 Arg2:T15	
T83	PROC 1030 1087	puntuación endoscópica simple para la enfermedad de Crohn
#69	AnnotatorNotes T83	C5549856; Assessment using Simple Endoscopic Score for Crohn's Disease; Health Care Activity
T84	PROC 1089 1095	SES-CD
#70	AnnotatorNotes T84	C5549856; Assessment using Simple Endoscopic Score for Crohn's Disease; Health Care Activity
R30	Overlap Arg1:T13 Arg2:T82	
R31	Overlap Arg1:T13 Arg2:T15	
R33	Overlap Arg1:T82 Arg2:T15	
R34	Overlap Arg1:T15 Arg2:T17	
R35	Overlap Arg1:T82 Arg2:T17	
R36	Causes Arg1:T18 Arg2:T43	
T85	Observation 1125 1145	respuesta inadecuada
#71	AnnotatorNotes T85	C0858218; Inappropriate drug response; Finding
R37	Overlap Arg1:T85 Arg2:T18	
R38	Experiences Arg1:T55 Arg2:T20	
R39	Experiences Arg1:T56 Arg2:T22	
R40	Experiences Arg1:T56 Arg2:T23	
R41	Overlap Arg1:T21 Arg2:T57	
R42	Experiences Arg1:T58 Arg2:T24	
R43	Experiences Arg1:T58 Arg2:T25	
R44	Has_Dose_or_Strength Arg1:T24 Arg2:T50	
R45	Overlap Arg1:T26 Arg2:T59	
R46	Before Arg1:T26 Arg2:T66	
R47	Has_Quantifier_or_Qualifier Arg1:T66 Arg2:T69	
R48	Overlap Arg1:T28 Arg2:T60	
R49	Overlap Arg1:T29 Arg2:T60	
R50	Before Arg1:T28 Arg2:T67	
R51	Before Arg1:T29 Arg2:T67	
R52	Has_Quantifier_or_Qualifier Arg1:T67 Arg2:T68	
R53	Before Arg1:T26 Arg2:T67	
R54	Before Arg1:T28 Arg2:T66	
R55	Before Arg1:T29 Arg2:T66	
R56	Causes Arg1:T35 Arg2:T34	
R57	Causes Arg1:T35 Arg2:T36	
R58	Location_of Arg1:T44 Arg2:T37	
R59	Causes Arg1:T35 Arg2:T37	
#72	AnnotatorNotes T37	C4476847; Short bowel; Congenital Abnormality
#12	AnnotatorNotes T18	C2945704; Conventional Treatment; Therapeutic or Preventive Procedure + C1531518; Biological treatment; Therapeutic or Preventive Procedure
A9	Experiencer T46 Patient
A10	Experiencer T47 Patient
A11	Experiencer T48 Patient
A12	Experiencer T61 Patient
A13	Experiencer T51 Patient
A14	Assertion T55 Hypothetical
A15	Experiencer T55 Patient
A16	Experiencer T56 Patient
A17	Experiencer T58 Patient
